302 related articles for article (PubMed ID: 22707276)
1. Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract.
Zappa M; Abdel-Rehim M; Hentic O; Vullierme MP; Ruszniewski P; Vilgrain V
Target Oncol; 2012 Jun; 7(2):107-16. PubMed ID: 22707276
[TBL] [Abstract][Full Text] [Related]
2. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
3. Ablative therapies for liver metastases of digestive endocrine tumours.
O'Toole D; Maire F; Ruszniewski P
Endocr Relat Cancer; 2003 Dec; 10(4):463-8. PubMed ID: 14713259
[TBL] [Abstract][Full Text] [Related]
4. Hepatic-directed Therapies in Patients with Neuroendocrine Tumors.
Kennedy AS
Hematol Oncol Clin North Am; 2016 Feb; 30(1):193-207. PubMed ID: 26614377
[TBL] [Abstract][Full Text] [Related]
5. Hepatic neuroendocrine metastases: does intervention alter outcomes?
Chamberlain RS; Canes D; Brown KT; Saltz L; Jarnagin W; Fong Y; Blumgart LH
J Am Coll Surg; 2000 Apr; 190(4):432-45. PubMed ID: 10757381
[TBL] [Abstract][Full Text] [Related]
6. [Interventional therapy of neuroendokrine tumors of the gastrointestinal tract].
Kettenbach J; Müller SL; Schindl M
Wien Klin Wochenschr; 2003; 115 Suppl 2():56-64. PubMed ID: 15518148
[TBL] [Abstract][Full Text] [Related]
7. Liver-directed therapies for metastatic neuroendocrine tumors.
Garrot C; Stuart K
Hematol Oncol Clin North Am; 2007 Jun; 21(3):545-60; ix-x. PubMed ID: 17548039
[TBL] [Abstract][Full Text] [Related]
8. Hepatic arterial embolization in patients with neuroendocrine tumors.
Del Prete M; Fiore F; Modica R; Marotta V; Marciello F; Ramundo V; Di Sarno A; Carratù A; di Roseto Cde L; Tafuto S; Tatangelo F; Baldelli R; Colao A; Faggiano A;
J Exp Clin Cancer Res; 2014 May; 33(1):43. PubMed ID: 24887262
[TBL] [Abstract][Full Text] [Related]
9. Catheter-based treatments for hepatic metastases from neuroendocrine tumors.
Kolbeck KJ; Farsad K
AJR Am J Roentgenol; 2014 Oct; 203(4):717-24. PubMed ID: 25247935
[TBL] [Abstract][Full Text] [Related]
10. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature.
Blonski WC; Reddy KR; Shaked A; Siegelman E; Metz DC
World J Gastroenterol; 2005 Dec; 11(48):7676-83. PubMed ID: 16437698
[TBL] [Abstract][Full Text] [Related]
12. Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours.
O'Toole D; Ruszniewski P
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):585-94. PubMed ID: 16183529
[TBL] [Abstract][Full Text] [Related]
13. Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver.
Kvols LK; Turaga KK; Strosberg J; Choi J
J Natl Compr Canc Netw; 2009 Jul; 7(7):765-72. PubMed ID: 19635229
[TBL] [Abstract][Full Text] [Related]
14. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
[TBL] [Abstract][Full Text] [Related]
15. Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver.
Wang SC; Fidelman N; Nakakura EK
Semin Oncol; 2013 Feb; 40(1):69-74. PubMed ID: 23391114
[TBL] [Abstract][Full Text] [Related]
16. [Transcatheter arterial chemoembolization (TACE) using degradable starch microspheres (DSM) (DSM-TACE) for primary and metastatic liver neuroendocrine tumors from gastrointestinal neuroendocrine tumors].
Fujisaki T; Ikari T; Kamei A; Takano K; Kuraoka K; Yoshimoto K; Hirasawa T; Asahara S
Nihon Shokakibyo Gakkai Zasshi; 2008 Feb; 105(2):206-13. PubMed ID: 18250591
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study.
Fiorentini G; Rossi S; Bonechi F; Vaira M; De Simone M; Dentico P; Bernardeschi P; Cantore M; Guadagni S
J Chemother; 2004 Jun; 16(3):293-7. PubMed ID: 15330328
[TBL] [Abstract][Full Text] [Related]
18. Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study.
Walter T; Lepage C; Coriat R; Barbier E; Cadiot G; Caroli-Bosc FX; Aparicio T; Bouhier-Leporrier K; Hentic-Dhome O; Gay F; Dupont-Gossart AC; Duluc M; Lepere C; Lecomte T; Smith D; Petorin C; Di-Fiore F; Ghiringhelli F; Legoux JL; Guimbaud R; Baudin E; Lombard-Bohas C; de Baère T;
Eur J Cancer; 2019 Dec; 123():92-100. PubMed ID: 31678771
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and therapy of liver metastases of neuroendocrine tumors].
Lehnert T; Knaebel HP
Chirurg; 1997 Feb; 68(2):122-31. PubMed ID: 9156977
[TBL] [Abstract][Full Text] [Related]
20. Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors.
Ruszniewski P; O'Toole D
Neuroendocrinology; 2004; 80 Suppl 1():74-8. PubMed ID: 15477722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
